Legend Biotech (LEGN) Operating Expenses (2019 - 2026)
Legend Biotech's (LEGN) quarterly Operating Expenses came in at $85.7 million in Q1 2026, up 21.67% YoY from $70.4 million in Q1 2025, and up 161.97% on a QoQ basis from -$138.3 million in Q4 2025.
Legend Biotech (LEGN) Operating Expenses (2019 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 8 years of Operating Expenses data on file, last reported at $85.7 million in Q1 2026.
- Quarterly Operating Expenses rose 21.67% year-over-year to $85.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$331.4 million (up 4.5% YoY) and the FY2025 annual result came in at -$550.5 million, changed 0.04% from the prior year.
- Operating Expenses improved to $85.7 million in Q1 2026, from -$138.3 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $85.7 million in Q1 2026 to a low of -$148.0 million in Q2 2024.
- A 5-year average of -$93.1 million and a median of -$124.0 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses tumbled 117898.15% — and 2025, when it soared 153.0%.
- Tracing LEGN's Operating Expenses over 5 years: stood at -$107.4 million in 2022, then soared by 99.87% to -$134390.0 in 2023, then tumbled by 103032.67% to -$138.6 million in 2024, then climbed by 0.22% to -$138.3 million in 2025, then soared by 161.97% to $85.7 million in 2026.
- The last three Operating Expenses figures came in at $85.7 million (Q1 2026), -$138.3 million (Q4 2025), and -$147.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | 96.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 96.00 Mn |
| Mar 31, 2026 | 85.70 Mn |
| Dec 31, 2025 | -138.30 Mn |
| Sep 30, 2025 | -147.87 Mn |
| Jun 30, 2025 | -130.90 Mn |
| Mar 31, 2025 | 70.44 Mn |
| Dec 31, 2024 | -138.60 Mn |
| Sep 30, 2024 | -130.82 Mn |
| Jun 30, 2024 | -147.98 Mn |
| Mar 31, 2024 | -132.89 Mn |
| Dec 31, 2023 | -134,390.00 |
| Sep 30, 2023 | -123.96 Mn |
| Jun 30, 2023 | -123.54 Mn |
| Mar 31, 2023 | -107.09 Mn |
| Dec 31, 2022 | -107.44 Mn |
| Sep 30, 2022 | -127.76 Mn |
| Jun 30, 2022 | -86.88 Mn |
| Mar 31, 2022 | -94.21 Mn |
| Dec 31, 2021 | -103.65 Mn |
| Sep 30, 2021 | -84.12 Mn |